BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 28,652,000 Value ($000) $28,353 Avg Close — Range —
Q2 2025
Shares 22,061,000 Value ($000) $20,658 Avg Close — Range —
Q1 2025
Shares 14,750,000 Value ($000) $13,260 Avg Close — Range —
Q4 2024
Shares 51,750,000 Value ($000) $44,138 Avg Close — Range —
Q3 2024
Shares 52,250,000 Value ($000) $43,763 Avg Close — Range —
Q2 2024
Shares 52,250,000 Value ($000) $42,211 Avg Close — Range —
Q1 2024
Shares 52,250,000 Value ($000) $42,963 Avg Close — Range —
Q4 2023
Shares 52,250,000 Value ($000) $43,990 Avg Close — Range —
Q3 2023
Shares 52,250,000 Value ($000) $39,237 Avg Close — Range —
Q2 2023
Shares 54,350,000 Value ($000) $33,641 Avg Close — Range —
Q1 2023
Shares 29,750,000 Value ($000) $18,824 Avg Close — Range —
Q1 2022
Shares 2,473,000 Value ($000) $1,191 Avg Close — Range —